These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. No-carrier-added regioselective preparation of 6-[18F]fluoro-L-dopa. Lemaire C; Guillaume M; Cantineau R; Christiaens L J Nucl Med; 1990 Jul; 31(7):1247-51. PubMed ID: 2113943 [TBL] [Abstract][Full Text] [Related]
5. New synthesis of fluorine-18-labeled 6-fluoro-L-dopa by cleaving the carbon-silicon bond with fluorine. Diksic M; Farrokhzad S J Nucl Med; 1985 Nov; 26(11):1314-8. PubMed ID: 3932611 [TBL] [Abstract][Full Text] [Related]
8. [Synthesis and determination for enantiomeric purity of 6-fluoro-L-DOPA]. Tang GH; Zhang L; Tang XL; Wang YX; Yin DZ Yao Xue Xue Bao; 2001 Oct; 36(10):739-42. PubMed ID: 12579971 [TBL] [Abstract][Full Text] [Related]
9. High yield synthesis of 6-[18F]fluoro-L-dopa. Chirakal R; Firnau G; Garnett ES J Nucl Med; 1986 Mar; 27(3):417-21. PubMed ID: 3086520 [TBL] [Abstract][Full Text] [Related]
10. One-step high-radiochemical-yield synthesis of [18F]FP-CIT using a protic solvent system. Lee SJ; Oh SJ; Chi DY; Kang SH; Kil HS; Kim JS; Moon DH Nucl Med Biol; 2007 May; 34(4):345-51. PubMed ID: 17499723 [TBL] [Abstract][Full Text] [Related]
11. [Fluorine-18 labeled 6-fluoro-L-dopa: systematization and evaluation of its usefulness]. Fujii R; Imahori Y; Kimura M; Toyama K; Yuasa M; Kumakura Y; Horii H; Wakita K; Yagyu T; Nakamura T; Ido T; Ueda S; Kanatsuna T Kaku Igaku; 1997 Nov; 34(11):1055-61. PubMed ID: 9455047 [TBL] [Abstract][Full Text] [Related]
12. Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET. Luxen A; Perlmutter M; Bida GT; Van Moffaert G; Cook JS; Satyamurthy N; Phelps ME; Barrio JR Int J Rad Appl Instrum A; 1990; 41(3):275-81. PubMed ID: 2158953 [TBL] [Abstract][Full Text] [Related]
14. Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa. Namavari M; Bishop A; Satyamurthy N; Bida G; Barrio JR Int J Rad Appl Instrum A; 1992 Aug; 43(8):989-96. PubMed ID: 1330984 [TBL] [Abstract][Full Text] [Related]
15. Metabolites of 6-[18F]fluoro-L-dopa in human blood. Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278 [TBL] [Abstract][Full Text] [Related]
16. Production at the Curie level of no-carrier-added 6-18F-fluoro-L-dopa. Libert LC; Franci X; Plenevaux AR; Ooi T; Maruoka K; Luxen AJ; Lemaire CF J Nucl Med; 2013 Jul; 54(7):1154-61. PubMed ID: 23658219 [TBL] [Abstract][Full Text] [Related]
17. Rapid synthesis of [18F]FDG without an evaporation step using an ionic liquid. Kim HW; Jeong JM; Lee YS; Chi DY; Chung KH; Lee DS; Chung JK; Lee MC Appl Radiat Isot; 2004 Dec; 61(6):1241-6. PubMed ID: 15388116 [TBL] [Abstract][Full Text] [Related]
19. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096 [TBL] [Abstract][Full Text] [Related]
20. Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone. Shiue CY; Fowler JS; Wolf AP; Watanabe M; Arnett CD J Nucl Med; 1985 Feb; 26(2):181-6. PubMed ID: 2857191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]